Fengming Zhong

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
164 Background: Palliative care interventions and their effect on EOL outcomes for liver cancer pts have not been described. We investigated the association between palliative care intervention and EOL care outcomes. METHODS We reviewed the charts of pts with hepatocellular carcinoma and who were seen by palliative care at 2 VA medical centers from 2006(More)
e14536 Background: Hepatocellular carcinoma (HCC) incidence is increasing in the United States. We compared the outcome of HCC patients (pts) over two consecutive decades for a VA population. METHODS In an IRB-approved protocol, we reviewed the records of pts with diagnosis (dx) of HCC seen at a VA Medical Center from 1/1/1990 to 12/31/2009. Demographics,(More)
The primary purpose of this study was to evaluate the event-based prospective memory (EBPM) and time-based prospective memory (TBPM) in androgen-deprivation therapy (ADT)-induced cognitive impairment in patients with prostate cancer (PC). Participants included PC patients who had undergone ADT (ADT group, n = 43) or patients who did not undergo ADT (non-ADT(More)
e15141 Background: The GS has been extensively proven to predict survival in early stages of PC for patients (pts) treated for cure. Limited information exists about its value as a predictor of survival for stages D2 and D3. We studied the relation between GS and survival for pts in stages D2 and D3. METHODS Retrospective analysis of 128 pts on stage D2(More)
48 Background: A Recursive Partitioning Analysis (RPA) prognostic algorithm based on quality of life and symptoms predicted 4 groups with distinct median survivals in patients with metastatic solid tumors receiving chemotherapy (ASCO 2013, Abst 9567). We update our findings. METHODS The RPA algorithm is based upon Karnofsky performance status (KPS),(More)
75 Background: Liver cancer is a leading cause of death. Lack of data exists on palliative care in this group, and care varies by location. We aim to determine if there are differences in palliative care for patients (pts) with liver cancer by VA site. METHODS In an IRB approved protocol, we reviewed medical records of pts at 2 VA medical centers (S1, S2)(More)
14519 Background: Cox-2 expression is an independent predictor of survival and is over expressed in 89.3% of pts with HRPC. Cox-2 expression has angiogenic and cytoprotective effects. Its suppression could lead to angiogenesis inhibition and increase chemotherapy sensitivity. D in low doses and C are angiogenesis inhibitors. The main objectives were to(More)
e14549 Background: To describe pts with pancreatic cancer and determine whether comorbidity indices predict survival. METHODS In an IRB-approved protocol, we reviewed the records of patients (pts) diagnosed with pancreatic cancer at a VA Medical Center from January 1999 to October 2009. Records were reviewed for demographic, clinical, pathological data,(More)
18598 Background: The impact of chemotherapy on QOL for pts with HRPC is not well described. Thirty patients(30) participated in a trial of D and C(Kasimis et al, submitted ASCO 2006). The objectives for this companion study were to study QOL outcomes with the FACT instrument including the Prostate subscale(FP) and utility from the EQ5D. METHODS In a(More)
e15682 Background: To determine whether comorbidity indices predict survival in hepatocellular carcinoma (HCC) pts. METHODS In an IRB approved protocol, we reviewed the records of pts with tissue diagnosis of HCC seen at a VA Medical Center between 1/1/1999 to 12/31/2008. Comorbidity was assessed with four comorbidity indices, the Charlson Comorbidity(More)